| Literature DB >> 15509536 |
Rebecca J Hodges1, R Gisli Jenkins, Caroline P D Wheeler-Jones, Danielle M Copeman, Stephen E Bottoms, Geoffrey J Bellingan, Carmel B Nanthakumar, Geoffrey J Laurent, Stephen L Hart, Martyn L Foster, Robin J McAnulty.
Abstract
Levels of prostaglandin E(2) (PGE(2)), a potent inhibitor of fibroblast function, are decreased in the lungs of patients with pulmonary fibrosis, which has been shown to be because of limited expression of cyclooxygenase-2 (COX-2). To further investigate the relative importance of COX-2 and PGE(2) in the development of fibrosis we have used a selective COX-2 inhibitor and COX-2-deficient ((-/-) and (+/-)) mice in studies of bleomycin-induced lung fibrosis. We demonstrate in wild-type mice that bleomycin-induced lung PGE(2) production is predominantly COX-2 mediated. Furthermore, COX-2(+/-) mice show limited induction of PGE(2) and an enhanced fibrotic response with increased lung collagen content compared with wild-type mice after bleomycin injury (P < 0.001). In contrast, COX-2(-/-) mice show increased levels of lung PGE(2), compared with wild-type mice after injury (P < 0.05), because of compensatory up-regulation of COX-1, which appears to be associated with macrophage/monocytes but not fibroblasts derived from these mice. COX-2(-/-) mice show an enhanced and persistent inflammatory response to bleomycin, however the fibrotic response to injury was unaltered compared with wild-type animals. These data provide further direct evidence for the importance of up-regulating COX-2 and PGE(2) expression in protecting against the development of fibrosis after lung injury.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15509536 PMCID: PMC1618657 DOI: 10.1016/S0002-9440(10)63423-2
Source DB: PubMed Journal: Am J Pathol ISSN: 0002-9440 Impact factor: 4.307